首页 > 最新文献

Molecular Genetics & Genomic Medicine最新文献

英文 中文
Reclassification of a spindle cell sarcoma after identification of a TFG-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma 发现 TFG-ROS1 融合后对纺锤细胞肉瘤进行重新分类:下一代测序技术在肉瘤临床治疗中的应用实例
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-15 DOI: 10.1002/mgg3.2423
John J. Lim, Eleanor Y. Chen, Stephanie K. Schaub, Michael J. Wagner
Inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal soft tissue sarcomas that often present diagnostic challenges due to their wide and varied morphology. A subset of IMTs have fusions involving ALK or ROS1. The role of next-generation sequencing (NGS) for classification of unselected sarcomas remains controversial.
炎性肌纤维母细胞瘤(IMT)是一种罕见的间叶软组织肉瘤,由于其形态广泛多样,常常给诊断带来困难。一部分 IMT 具有涉及 ALK 或 ROS1 的融合。下一代测序(NGS)在未经选择的肉瘤分类中的作用仍存在争议。
{"title":"Reclassification of a spindle cell sarcoma after identification of a TFG-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma","authors":"John J. Lim, Eleanor Y. Chen, Stephanie K. Schaub, Michael J. Wagner","doi":"10.1002/mgg3.2423","DOIUrl":"https://doi.org/10.1002/mgg3.2423","url":null,"abstract":"Inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal soft tissue sarcomas that often present diagnostic challenges due to their wide and varied morphology. A subset of IMTs have fusions involving <i>ALK or ROS1.</i> The role of next-generation sequencing (NGS) for classification of unselected sarcomas remains controversial.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genotype and phenotype in patients with ACAN gene variants: Three cases and literature review ACAN 基因变异患者的基因型和表型:三个病例和文献综述
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-13 DOI: 10.1002/mgg3.2439
Wei Tang, Ke‐Mi Wu, Qiong Zhou, Yan‐Fei Tang, Jun‐Fen Fu, Guan‐Ping Dong, Chao‐Chun Zou
ObjectiveTo characterize the phenotype spectrum, diagnosis, and response to growth‐promoting therapy in patients with ACAN variants causing familial short stature.MethodsThree families with ACAN variants causing short stature were reported. Similar cases in the literature were summarized, and the genotype and phenotype were analyzed.ResultsThree novel heterozygous variants, c.757+1G>A, (splicing), c.6229delG, p.(Asp2078Tfs*1), and c.6679C>T, p.(Gln2227*) in the ACAN gene were identified. A total of 314 individuals with heterozygous variants from 105 families and 8 individuals with homozygous variants from 4 families were confirmed to have ACAN variants from literature and our 3 cases. Including our 3 cases, the variants reported comprised 33 frameshift, 39 missense, 23 nonsense, 5 splicing, 4 deletion, and 1 translocation variants. Variation points are scattered throughout the gene, while exons 12, 15, and 10 were most common (25/105, 11/105, and 10/105, respectively). Some identical variants existing in different families could be hot variants, c.532A>T, p.(Asn178Tyr), c.1411C>T, p.(Gln471*), c.1608C>A, p.(Tyr536*), c.2026+1G>A, (splicing), and c.7276G>T, p.(Glu2426*). Short stature, early‐onset osteoarthritis, brachydactyly, midfacial hypoplasia, and early growth cessation were the common phenotypic features. The 48 children who received rhGH (and GnRHa) treatment had a significant height improvement compared with before (−2.18 ± 1.06 SD vs. −2.69 ± 0.95 SD, p < 0.001). The heights of children who received rhGH (and GnRHa) treatment were significantly improved compared with those of untreated adults (−2.20 ± 1.10 SD vs. −3.24 ± 1.14 SD, p < 0.001).ConclusionOur study achieves a new understanding of the phenotypic spectrum, diagnosis, and management of individuals with ACAN variants. No clear genotype–phenotype relationship of patients with ACAN variants was found. Gene sequencing is necessary to diagnose ACAN variants that cause short stature. In general, appropriate rhGH and/or GnRHa therapy can improve the adult height of affected pediatric patients caused by ACAN variants.
目的描述ACAN变异导致家族性身材矮小患者的表型谱、诊断和对促进生长治疗的反应。方法报告了三个ACAN变异导致身材矮小的家族。结果在 ACAN 基因中发现了 c.757+1G>A(剪接)、c.6229delG、p.(Asp2078Tfs*1) 和 c.6679C>T、p.(Gln2227*)三个新的杂合变异。共有来自105个家庭的314名杂合变异个体和来自4个家庭的8名同源变异个体从文献和我们的3个病例中被证实患有ACAN变异。包括我们的 3 个病例在内,报告的变异包括 33 个移框变异、39 个错义变异、23 个无义变异、5 个剪接变异、4 个缺失变异和 1 个易位变异。变异点散布在整个基因中,而外显子 12、15 和 10 最为常见(分别为 25/105、11/105 和 10/105)。不同家族中存在的一些相同变异可能是热变异,如 c.532A>T,p.(Asn178Tyr)、c.1411C>T,p.(Gln471*)、c.1608C>A,p.(Tyr536*)、c.2026+1G>A(剪接)和 c.7276G>T,p.(Glu2426*)。身材矮小、早发骨关节炎、手足畸形、中面部发育不全和早期生长停止是常见的表型特征。接受rhGH(和GnRHa)治疗的48名儿童的身高与治疗前相比有显著改善(-2.18 ± 1.06 SD vs. -2.69 ± 0.95 SD,p <0.001)。与未接受治疗的成人相比,接受 rhGH(和 GnRHa)治疗的儿童身高有明显改善(-2.20 ± 1.10 SD vs. -3.24 ± 1.14 SD,p < 0.001)。ACAN变体患者的基因型与表型之间没有明确的关系。要诊断导致身材矮小的 ACAN 变体,必须进行基因测序。一般来说,适当的rhGH和/或GnRHa疗法可改善由ACAN变异体引起的受影响儿童患者的成年身高。
{"title":"Genotype and phenotype in patients with ACAN gene variants: Three cases and literature review","authors":"Wei Tang, Ke‐Mi Wu, Qiong Zhou, Yan‐Fei Tang, Jun‐Fen Fu, Guan‐Ping Dong, Chao‐Chun Zou","doi":"10.1002/mgg3.2439","DOIUrl":"https://doi.org/10.1002/mgg3.2439","url":null,"abstract":"ObjectiveTo characterize the phenotype spectrum, diagnosis, and response to growth‐promoting therapy in patients with <jats:italic>ACAN</jats:italic> variants causing familial short stature.MethodsThree families with <jats:italic>ACAN</jats:italic> variants causing short stature were reported. Similar cases in the literature were summarized, and the genotype and phenotype were analyzed.ResultsThree novel heterozygous variants, c.757+1G&gt;A, (splicing), c.6229delG, p.(Asp2078Tfs*1), and c.6679C&gt;T, p.(Gln2227*) in the <jats:italic>ACAN</jats:italic> gene were identified. A total of 314 individuals with heterozygous variants from 105 families and 8 individuals with homozygous variants from 4 families were confirmed to have <jats:italic>ACAN</jats:italic> variants from literature and our 3 cases. Including our 3 cases, the variants reported comprised 33 frameshift, 39 missense, 23 nonsense, 5 splicing, 4 deletion, and 1 translocation variants. Variation points are scattered throughout the gene, while exons 12, 15, and 10 were most common (25/105, 11/105, and 10/105, respectively). Some identical variants existing in different families could be hot variants, c.532A&gt;T, p.(Asn178Tyr), c.1411C&gt;T, p.(Gln471*), c.1608C&gt;A, p.(Tyr536*), c.2026+1G&gt;A, (splicing), and c.7276G&gt;T, p.(Glu2426*). Short stature, early‐onset osteoarthritis, brachydactyly, midfacial hypoplasia, and early growth cessation were the common phenotypic features. The 48 children who received rhGH (and GnRHa) treatment had a significant height improvement compared with before (−2.18 ± 1.06 SD vs. −2.69 ± 0.95 SD, <jats:italic>p</jats:italic> &lt; 0.001). The heights of children who received rhGH (and GnRHa) treatment were significantly improved compared with those of untreated adults (−2.20 ± 1.10 SD vs. −3.24 ± 1.14 SD, <jats:italic>p</jats:italic> &lt; 0.001).ConclusionOur study achieves a new understanding of the phenotypic spectrum, diagnosis, and management of individuals with <jats:italic>ACAN</jats:italic> variants. No clear genotype–phenotype relationship of patients with <jats:italic>ACAN</jats:italic> variants was found. Gene sequencing is necessary to diagnose <jats:italic>ACAN</jats:italic> variants that cause short stature. In general, appropriate rhGH and/or GnRHa therapy can improve the adult height of affected pediatric patients caused by <jats:italic>ACAN</jats:italic> variants.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Further delineation of phenotype and genotype of Kenny–Caffey syndrome type 2 (phenotype and genotype of KCS type 2) 进一步确定肯尼-卡菲综合征 2 型的表型和基因型(肯尼-卡菲综合征 2 型的表型和基因型)
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-09 DOI: 10.1002/mgg3.2433
Xuefei Chen, Chaochun Zou
BackgroundKenny–Caffey syndrome type 2 (KCS2) is an extremely rare inherited disorder characterized by proportionate short stature, skeletal defects, ocular and dental abnormalities, and transient hypocalcemia. It is caused by variants in FAM111A gene. Diagnosis of KCS2 can be challenging because of its similarities to other syndromes, the absence of clear hallmarks and the deficient number of genetically confirmed cases. Here, we aimed to further delineate and summarize the genotype and phenotype of KCS2, in order to get a better understanding of this rare disorder, and promote early diagnosis and intervention.MethodsWe present clinical and genetic characteristics of eight newly affected individuals with KCS2 from six families, including one family with three individuals found to be a father‐to‐daughter transmission, adding to the limited literature. Furthermore, we performed a review of genetically confirmed KCS2 cases in PubMed, MEDLINE and CNKI databases.ResultsThere were six females and two males in our cohort. All the patients presented with short stature (100.0%). Clinical manifestations included ocular defects such as hypermetropia (5/8), dental problems such as defective dentition (3/8) and dental caries (3/8), skeletal and brain anomalies such as delayed closure of anterior fontanelle (6/8), cerebral calcification (3/8), cortical thickening (3/8) and medullary stenosis (4/8) of tubular bones. Endocrinologic abnormalities included hypoparathyroidism (5/8) and hypocalcemia (3/8). One male patient had micropenis and microorchidism. All cases harboured missense variants of FAM111A, and nucleotides c.1706 arose as a mutational hotspot, with seven individuals harbouring a c.1706G>A (p.Arg569His) variant, and one child harbouring a c.1531T>C (p.Tyr511His) variant. Literature review yielded a total of 46 patients from 20 papers. Data analysis showed that short stature, hypoparathyroidism and hypocalcemia, ocular and dental defects, skeletal features including cortical thickening and medullary stenosis of tubular bones, and seizures/spasms were present in more than 70% of the reported KCS2 cases.ConclusionWe provide detailed characteristics of the largest KCS2 group in China and present the first genetically confirmed instance of father‐to‐daughter transmission of KCS2. Our study confirms that Arg569His is the hot spot variant and summarizes the typical phenotypes of KCS2, which would help early diagnosis and intervention.
背景肯尼-卡菲综合征 2 型(KCS2)是一种极其罕见的遗传性疾病,以身材矮小、骨骼缺陷、眼部和牙齿异常以及一过性低钙血症为特征。它是由 FAM111A 基因变异引起的。由于 KCS2 与其他综合征相似,缺乏明确的特征,且遗传学确诊病例数量不足,因此诊断 KCS2 具有挑战性。在此,我们旨在进一步描述和总结 KCS2 的基因型和表型,以便更好地了解这种罕见疾病,促进早期诊断和干预。方法我们介绍了来自 6 个家庭的 8 名新患 KCS2 患者的临床和遗传特征,其中一个家庭的 3 名患者被发现是父女相传,为有限的文献资料增添了新的内容。此外,我们还查阅了 PubMed、MEDLINE 和 CNKI 数据库中经基因证实的 KCS2 病例。所有患者均表现为身材矮小(100.0%)。临床表现包括眼部缺陷(5/8)、牙齿问题(3/8)和龋齿(3/8)、骨骼和大脑异常(6/8)、大脑钙化(3/8)、皮质增厚(3/8)和管状骨髓狭窄(4/8)。内分泌异常包括甲状旁腺功能减退(5/8)和低钙血症(3/8)。一名男性患者患有小阴茎和小睾丸症。所有病例均携带FAM111A的错义变异,c.1706核苷酸是突变热点,其中7人携带c.1706G>A(p.Arg569His)变异,1名儿童携带c.1531T>C(p.Tyr511His)变异。文献综述共收集到 20 篇论文中的 46 名患者。数据分析显示,70%以上的KCS2病例存在身材矮小、甲状旁腺功能减退和低钙血症、眼部和牙齿缺陷、骨骼特征(包括皮质增厚和管状骨髓状狭窄)以及癫痫发作/痉挛。我们的研究证实 Arg569His 是热点变异,并总结了 KCS2 的典型表型,这将有助于早期诊断和干预。
{"title":"Further delineation of phenotype and genotype of Kenny–Caffey syndrome type 2 (phenotype and genotype of KCS type 2)","authors":"Xuefei Chen, Chaochun Zou","doi":"10.1002/mgg3.2433","DOIUrl":"https://doi.org/10.1002/mgg3.2433","url":null,"abstract":"BackgroundKenny–Caffey syndrome type 2 (KCS2) is an extremely rare inherited disorder characterized by proportionate short stature, skeletal defects, ocular and dental abnormalities, and transient hypocalcemia. It is caused by variants in <jats:italic>FAM111A</jats:italic> gene. Diagnosis of KCS2 can be challenging because of its similarities to other syndromes, the absence of clear hallmarks and the deficient number of genetically confirmed cases. Here, we aimed to further delineate and summarize the genotype and phenotype of KCS2, in order to get a better understanding of this rare disorder, and promote early diagnosis and intervention.MethodsWe present clinical and genetic characteristics of eight newly affected individuals with KCS2 from six families, including one family with three individuals found to be a father‐to‐daughter transmission, adding to the limited literature<jats:italic>.</jats:italic> Furthermore, we performed a review of genetically confirmed KCS2 cases in PubMed, MEDLINE and CNKI databases.ResultsThere were six females and two males in our cohort. All the patients presented with short stature (100.0%). Clinical manifestations included ocular defects such as hypermetropia (5/8), dental problems such as defective dentition (3/8) and dental caries (3/8), skeletal and brain anomalies such as delayed closure of anterior fontanelle (6/8), cerebral calcification (3/8), cortical thickening (3/8) and medullary stenosis (4/8) of tubular bones. Endocrinologic abnormalities included hypoparathyroidism (5/8) and hypocalcemia (3/8). One male patient had micropenis and microorchidism. All cases harboured missense variants of <jats:italic>FAM111A</jats:italic>, and nucleotides c.1706 arose as a mutational hotspot, with seven individuals harbouring a c.1706G&gt;A (p.Arg569His) variant, and one child harbouring a c.1531T&gt;C (p.Tyr511His) variant. Literature review yielded a total of 46 patients from 20 papers. Data analysis showed that short stature, hypoparathyroidism and hypocalcemia, ocular and dental defects, skeletal features including cortical thickening and medullary stenosis of tubular bones, and seizures/spasms were present in more than 70% of the reported KCS2 cases.ConclusionWe provide detailed characteristics of the largest KCS2 group in China and present the first genetically confirmed instance of father‐to‐daughter transmission of KCS2. Our study confirms that Arg569His is the hot spot variant and summarizes the typical phenotypes of KCS2, which would help early diagnosis and intervention.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical value of optical genome mapping in the rapid characterization of RB1 duplication and 15q23q24.2 triplication, for more appropriate prenatal genetic counselling 光学基因组图谱在快速鉴定 RB1 复制和 15q23q24.2 三重复制方面的临床价值,以提供更适当的产前遗传咨询
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-08 DOI: 10.1002/mgg3.2437
Malek Bouassida, Denise Molina‐Gomes, Fairouz Koraichi, Bérénice Hervé, Morgane Lhuilier, Clémence Duvillier, Jessica Le Gall, Marion Gauthier‐Villars, Valérie Serazin, Thibaud Quibel, Rodolphe Dard, François Vialard
BackgroundDespite recent advances in prenatal genetic diagnosis, medical geneticists still face considerable difficulty in interpreting the clinical outcome of copy‐number‐variant duplications and defining the mechanisms underlying the formation of certain chromosomal rearrangements.Optical genome mapping (OGM) is an emerging cytogenomic tool with proved ability to identify the full spectrum of cytogenetic aberrations.MethodsHere, we report on the use of OGM in a prenatal diagnosis setting. Detailed breakpoint mapping was used to determine the relative orientations of triplicated and duplicated segments in two unrelated foetuses harbouring chromosomal aberrations: a de novo 15q23q24.2 triplication and a paternally inherited 13q14.2 duplication that overlapped partially with the RB1 gene.ResultsOGM enabled us to suggest a plausible mechanism for the triplication and confirmed that the RB1 duplication was direct oriented and in tandem. This enabled us to predict the pathogenic consequences, refine the prognosis and adapt the follow‐up and familial screening appropriately.ConclusionAlong with an increase in diagnostic rates, OGM can rapidly highlight genotype–phenotype correlations, improve genetic counselling and significantly influence prenatal management.
背景尽管产前基因诊断取得了最新进展,但医学遗传学家在解释拷贝数变异重复的临床结果和确定某些染色体重排的形成机制方面仍面临相当大的困难。方法在此,我们报告了在产前诊断中使用光学基因组测绘(OGM)的情况。我们利用详细的断点图谱确定了两个无血缘关系胎儿染色体畸变的三倍段和重复段的相对方向:一个是新发的 15q23q24.2 三倍段,另一个是父系遗传的 13q14.2 重复段,该重复段与 RB1 基因部分重叠。结果OGM 使我们能够提出三倍段的合理机制,并证实 RB1 重复段是直接定向和串联的。结论随着诊断率的提高,OGM 可以迅速突出基因型与表型的相关性,改善遗传咨询,并对产前管理产生重大影响。
{"title":"The clinical value of optical genome mapping in the rapid characterization of RB1 duplication and 15q23q24.2 triplication, for more appropriate prenatal genetic counselling","authors":"Malek Bouassida, Denise Molina‐Gomes, Fairouz Koraichi, Bérénice Hervé, Morgane Lhuilier, Clémence Duvillier, Jessica Le Gall, Marion Gauthier‐Villars, Valérie Serazin, Thibaud Quibel, Rodolphe Dard, François Vialard","doi":"10.1002/mgg3.2437","DOIUrl":"https://doi.org/10.1002/mgg3.2437","url":null,"abstract":"BackgroundDespite recent advances in prenatal genetic diagnosis, medical geneticists still face considerable difficulty in interpreting the clinical outcome of copy‐number‐variant duplications and defining the mechanisms underlying the formation of certain chromosomal rearrangements.Optical genome mapping (OGM) is an emerging cytogenomic tool with proved ability to identify the full spectrum of cytogenetic aberrations.MethodsHere, we report on the use of OGM in a prenatal diagnosis setting. Detailed breakpoint mapping was used to determine the relative orientations of triplicated and duplicated segments in two unrelated foetuses harbouring chromosomal aberrations: a de novo 15q23q24.2 triplication and a paternally inherited 13q14.2 duplication that overlapped partially with the <jats:italic>RB1</jats:italic> gene.ResultsOGM enabled us to suggest a plausible mechanism for the triplication and confirmed that the <jats:italic>RB1</jats:italic> duplication was direct oriented and <jats:italic>in tandem</jats:italic>. This enabled us to predict the pathogenic consequences, refine the prognosis and adapt the follow‐up and familial screening appropriately.ConclusionAlong with an increase in diagnostic rates, OGM can rapidly highlight genotype–phenotype correlations, improve genetic counselling and significantly influence prenatal management.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review 一例由 RBCK1 基因变异引起的多葡聚糖体肌病及文献综述
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-08 DOI: 10.1002/mgg3.2432
Qiqing Sun, Zhenhua Xie, Lifang Song, Dapeng Fu
ObjectiveTo analyze the clinical and genetic characteristics of a patient with Polyglucosan body myopathy 1 (PGBM1) caused by a novel compound heterozygous variant in the RBCK1 gene.MethodsThe clinical data of the patient were collected, next‐generation sequencing technology was used to determine the exome sequence of the patient, and the suspected pathogenic locus was verified by Sanger sequencing.ResultsThrough whole‐exome sequencing, we found that there were c.919G>T; p. (Glu307*) and c.723_730dup; p. (Glu244fs) variants of the RBCK1 gene in the patient, inherited from his parents, constituting a compound heterozygous variation. According to the guidelines of the American College of Medical Genetics and Genomics (ACMG), the two variants were rated as pathogenic, but there were no comparable cases. Previous literature reported 24 patients with RBCK1 gene variants, involving a total of 20 myocardial and 18 skeletal muscle cases.ConclusionsThe patient was twice diagnosed with cardiac insufficiency, neglecting the usual manifestations of muscle weakness, resulting in misdiagnosis. Later, novel variants in the RBCK1 gene were discovered through whole‐exome sequencing, and symptomatic treatment was given after diagnosis. The importance of whole‐exome sequencing technology in disease diagnosis and genetic counseling was emphasized.
方法 收集患者的临床资料,利用新一代测序技术测定患者的外显子组序列,并通过 Sanger 测序验证疑似致病位点。G>T;p.(Glu307*)和 c.723_730dup;p.(Glu244fs)变异,构成复合杂合变异。根据美国医学遗传学和基因组学学会(ACMG)的指南,这两个变异被评为致病性变异,但没有可比病例。结论该患者两次被诊断为心功能不全,忽视了肌无力的通常表现,导致误诊。后来,通过全外显子组测序发现了 RBCK1 基因的新型变异,并在确诊后给予了对症治疗。会议强调了全外显子组测序技术在疾病诊断和遗传咨询中的重要性。
{"title":"A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review","authors":"Qiqing Sun, Zhenhua Xie, Lifang Song, Dapeng Fu","doi":"10.1002/mgg3.2432","DOIUrl":"https://doi.org/10.1002/mgg3.2432","url":null,"abstract":"ObjectiveTo analyze the clinical and genetic characteristics of a patient with Polyglucosan body myopathy 1 (PGBM1) caused by a novel compound heterozygous variant in the <jats:italic>RBCK1</jats:italic> gene.MethodsThe clinical data of the patient were collected, next‐generation sequencing technology was used to determine the exome sequence of the patient, and the suspected pathogenic locus was verified by Sanger sequencing.ResultsThrough whole‐exome sequencing, we found that there were c.919G&gt;T; p. (Glu307*) and c.723_730dup; p. (Glu244fs) variants of the <jats:italic>RBCK1</jats:italic> gene in the patient, inherited from his parents, constituting a compound heterozygous variation. According to the guidelines of the American College of Medical Genetics and Genomics (ACMG), the two variants were rated as pathogenic, but there were no comparable cases. Previous literature reported 24 patients with <jats:italic>RBCK1</jats:italic> gene variants, involving a total of 20 myocardial and 18 skeletal muscle cases.ConclusionsThe patient was twice diagnosed with cardiac insufficiency, neglecting the usual manifestations of muscle weakness, resulting in misdiagnosis. Later, novel variants in the <jats:italic>RBCK1</jats:italic> gene were discovered through whole‐exome sequencing, and symptomatic treatment was given after diagnosis. The importance of whole‐exome sequencing technology in disease diagnosis and genetic counseling was emphasized.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autism spectrum disorder profiles in RASopathies: A systematic review RAS病的自闭症谱系障碍特征:系统综述
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-06 DOI: 10.1002/mgg3.2428
Edward Debbaut, Jean Steyaert, Mouna El Bakkali
BackgroundRASopathies are associated with an increased risk of autism spectrum disorder (ASD). For neurofibromatosis type 1 (NF1) there is ample evidence for this increased risk, while for other RASopathies this association has been studied less. No specific ASD profile has been delineated so far for RASopathies or a specific RASopathy individually.MethodsWe conducted a systematic review to investigate whether a specific RASopathy is associated with a specific ASD profile, or if RASopathies altogether have a distinct ASD profile compared to idiopathic ASD (iASD). We searched PubMed, Web of Science, and Open Grey for data about ASD features in RASopathies and potential modifiers.ResultsWe included 41 articles on ASD features in NF1, Noonan syndrome (NS), Costello syndrome (CS), and cardio‐facio‐cutaneous syndrome (CFC). Individuals with NF1, NS, CS, and CFC on average have higher ASD symptomatology than healthy controls and unaffected siblings, though less than people with iASD. There is insufficient evidence for a distinct ASD phenotype in RASopathies compared to iASD or when RASopathies are compared with each other. We identified several potentially modifying factors of ASD symptoms in RASopathies.ConclusionsOur systematic review found no convincing evidence for a specific ASD profile in RASopathies compared to iASD, or in a specific RASopathy compared to other RASopathies. However, we identified important limitations in the research literature which may also account for this result. These limitations are discussed and recommendations for future research are formulated.
背景RAS病与自闭症谱系障碍(ASD)风险增加有关。对于 1 型神经纤维瘤病 (NF1),有大量证据表明这种风险会增加,而对于其他 RAS 病,这种关联的研究较少。我们进行了一项系统性综述,以研究特定的 RAS 病是否与特定的 ASD 特征相关,或者与特发性 ASD(iASD)相比,RAS 病是否具有独特的 ASD 特征。我们在PubMed、Web of Science和Open Grey上搜索了有关RAS病的ASD特征和潜在修饰因素的数据。结果我们收录了41篇有关NF1、努南综合征(NS)、科斯特罗综合征(CS)和心-面-皮肤综合征(CFC)的ASD特征的文章。NF1、NS、CS和CFC患者的ASD症状平均高于健康对照组和未受影响的兄弟姐妹,但低于iASD患者。目前还没有足够的证据表明,与iASD相比,或当RAS病相互比较时,RAS病具有独特的ASD表型。结论我们的系统综述没有发现令人信服的证据表明,与 iASD 相比,或与其他 RAS 病相比,RAS 病具有特定的 ASD 特征。不过,我们也发现了研究文献中的一些重要局限性,这些局限性也可能是造成这一结果的原因。我们对这些局限性进行了讨论,并为今后的研究提出了建议。
{"title":"Autism spectrum disorder profiles in RASopathies: A systematic review","authors":"Edward Debbaut, Jean Steyaert, Mouna El Bakkali","doi":"10.1002/mgg3.2428","DOIUrl":"https://doi.org/10.1002/mgg3.2428","url":null,"abstract":"BackgroundRASopathies are associated with an increased risk of autism spectrum disorder (ASD). For neurofibromatosis type 1 (NF1) there is ample evidence for this increased risk, while for other RASopathies this association has been studied less. No specific ASD profile has been delineated so far for RASopathies or a specific RASopathy individually.MethodsWe conducted a systematic review to investigate whether a specific RASopathy is associated with a specific ASD profile, or if RASopathies altogether have a distinct ASD profile compared to idiopathic ASD (iASD). We searched PubMed, Web of Science, and Open Grey for data about ASD features in RASopathies and potential modifiers.ResultsWe included 41 articles on ASD features in NF1, Noonan syndrome (NS), Costello syndrome (CS), and cardio‐facio‐cutaneous syndrome (CFC). Individuals with NF1, NS, CS, and CFC on average have higher ASD symptomatology than healthy controls and unaffected siblings, though less than people with iASD. There is insufficient evidence for a distinct ASD phenotype in RASopathies compared to iASD or when RASopathies are compared with each other. We identified several potentially modifying factors of ASD symptoms in RASopathies.ConclusionsOur systematic review found no convincing evidence for a specific ASD profile in RASopathies compared to iASD, or in a specific RASopathy compared to other RASopathies. However, we identified important limitations in the research literature which may also account for this result. These limitations are discussed and recommendations for future research are formulated.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and genetic characteristics of three patients with congenital insensitivity to pain with anhidrosis: Case reports and a review of the literature 三例先天性痛觉不敏感合并无汗症患者的临床和遗传特征:病例报告和文献综述
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-06 DOI: 10.1002/mgg3.2430
Jun Hee Cho, Soojin Hwang, Yoon Hae Kwak, Mi‐Sun Yum, Go Hun Seo, June‐Young Koh, Young Seok Ju, Ji‐Hee Yoon, Minji Kang, Hyo‐Sang Do, Soyoung Kim, Gu‐Hwan Kim, Hyunwoo Bae, Beom Hee Lee
BackgroundCongenital insensitivity to pain with anhidrosis (CIPA) is an extremely rare autosomal recessive disorder caused by loss‐of‐function mutations of the NTRK1 gene, affecting the autonomic and sensory nervous system. Clinical manifestation is varied and includes recurrent fever, pain insensitivity, anhidrosis, self‐mutilating behavior, and intellectual disability.MethodsClinical and genetic features were assessed in two males and one female with genetically confirmed CIPA using exome or genome sequencing.ResultsCIPA symptoms including recurrent fever, pain insensitivity, and anhidrosis manifested at the age of 1 year (age range: 0.3–8 years). Two patients exhibited self‐mutilation tendencies, intellectual disability, and developmental delay. Four NTRK1 (NM_002529.3) mutations, c.851‐33T>A (p.?), c.2020G>T (p.Asp674Tyr), c.2303C>T (p.Pro768Leu), and c.574‐156_850+1113del (exons 5‐7 del) were identified. Two patients exhibited early onset and severe phenotype, being homozygous for c.851‐33T>A (p.?) mutations and compound heterozygous for c.851‐33T>A (p.?) and c.2020G>T (p.Asp674Tyr) mutation of NTRK1. The third patient with compound heterozygous mutations of c.2303C>T (p.Pro768Leu) and c.574‐156_850+1113del (exons 5‐7 del) displayed a late onset and milder clinical manifestation.ConclusionAll three patients exhibited variable phenotypes and disease severity. This research enriches our understanding of clinical and genetic aspects of CIPA, highlighting variable phenotypes and disease severity.
背景先天性痛觉不敏感伴潮湿症(CIPA)是一种极其罕见的常染色体隐性遗传疾病,由NTRK1基因功能缺失突变引起,影响自主神经和感觉神经系统。临床表现多种多样,包括反复发热、对疼痛不敏感、多汗症、自残行为和智力障碍。两名患者有自残倾向、智力障碍和发育迟缓。发现了四种 NTRK1(NM_002529.3)突变,分别为 c.851-33T>A(p.?)、c.2020G>T(p.Asp674Tyr)、c.2303C>T(p.Pro768Leu)和 c.574-156_850+1113del(5-7 del 外显子)。两名患者表现出早发和严重的表型,分别是NTRK1的c.851-33T>A(p.?)突变的同源杂合子和c.851-33T>A(p.?)和c.2020G>T(p.Asp674Tyr)突变的复合杂合子。第三位患者为c.2303C>T(p.Pro768Leu)和c.574-156_850+1113del(5-7 del外显子)复合杂合突变,起病较晚,临床表现较轻。这项研究丰富了我们对 CIPA 临床和遗传方面的认识,突出了不同的表型和疾病严重程度。
{"title":"Clinical and genetic characteristics of three patients with congenital insensitivity to pain with anhidrosis: Case reports and a review of the literature","authors":"Jun Hee Cho, Soojin Hwang, Yoon Hae Kwak, Mi‐Sun Yum, Go Hun Seo, June‐Young Koh, Young Seok Ju, Ji‐Hee Yoon, Minji Kang, Hyo‐Sang Do, Soyoung Kim, Gu‐Hwan Kim, Hyunwoo Bae, Beom Hee Lee","doi":"10.1002/mgg3.2430","DOIUrl":"https://doi.org/10.1002/mgg3.2430","url":null,"abstract":"BackgroundCongenital insensitivity to pain with anhidrosis (CIPA) is an extremely rare autosomal recessive disorder caused by loss‐of‐function mutations of the <jats:italic>NTRK1</jats:italic> gene, affecting the autonomic and sensory nervous system. Clinical manifestation is varied and includes recurrent fever, pain insensitivity, anhidrosis, self‐mutilating behavior, and intellectual disability.MethodsClinical and genetic features were assessed in two males and one female with genetically confirmed CIPA using exome or genome sequencing.ResultsCIPA symptoms including recurrent fever, pain insensitivity, and anhidrosis manifested at the age of 1 year (age range: 0.3–8 years). Two patients exhibited self‐mutilation tendencies, intellectual disability, and developmental delay. Four <jats:italic>NTRK1</jats:italic> (NM_002529.3) mutations, c.851‐33T&gt;A (p.?), c.2020G&gt;T (p.Asp674Tyr), c.2303C&gt;T (p.Pro768Leu), and c.574‐156_850+1113del (exons 5‐7 del) were identified. Two patients exhibited early onset and severe phenotype, being homozygous for c.851‐33T&gt;A (p.?) mutations and compound heterozygous for c.851‐33T&gt;A (p.?) and c.2020G&gt;T (p.Asp674Tyr) mutation of <jats:italic>NTRK1</jats:italic>. The third patient with compound heterozygous mutations of c.2303C&gt;T (p.Pro768Leu) and c.574‐156_850+1113del (exons 5‐7 del) displayed a late onset and milder clinical manifestation.ConclusionAll three patients exhibited variable phenotypes and disease severity. This research enriches our understanding of clinical and genetic aspects of CIPA, highlighting variable phenotypes and disease severity.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and validation of a novel anoikis‐related prognostic model for prostate cancer 鉴定和验证新型前列腺癌免疫相关预后模型
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-04 DOI: 10.1002/mgg3.2419
Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Feng
BackgroundAnoikis resistance is a hallmark characteristic of oncogenic transformation, which is crucial for tumor progression and metastasis. The aim of this study was to identify and validate a novel anoikis‐related prognostic model for prostate cancer (PCa).MethodsWe collected a gene expression profile, single nucleotide polymorphism mutation and copy number variation (CNV) data of 495 PCa patients from the TCGA database and 140 PCa samples from the MSKCC dataset. We extracted 434 anoikis‐related genes and unsupervised consensus cluster analysis was used to identify molecular subtypes. The immune infiltration, molecular function, and genome alteration of subtypes were evaluated. A risk signature was developed using Cox regression analysis and validated with the MSKCC dataset. We also identify potential drugs for high‐risk group patients.ResultsTwo subtypes were identified. C1 exhibited a higher level of CNV amplification, immune score, stromal score, aneuploidy score, homologous recombination deficiency, intratumor heterogeneity, single‐nucleotide variant neoantigens, and tumor mutational burden compared to C2. C2 showed a better survival outcome and had a high level of gamma delta T cell and activated B cell infiltration. The risk signature consisting of four genes (HELLS, ZWINT, ABCC5, and TPSB2) was developed (area under the curve = 0.780) and was found to be an independent prognostic factor for overall survival in PCa patients. Four CTRP‐derived and four PRISM‐derived compounds were identified for high‐risk patients.ConclusionsThe anoikis‐related prognostic model developed in this study could be a useful tool for clinical decision‐making. This study may provide a new perspective for the treatment of anoikis‐related PCa.
背景肿瘤耐药是致癌转化的一个标志性特征,对肿瘤的进展和转移至关重要。方法 我们从 TCGA 数据库中收集了 495 例 PCa 患者的基因表达谱、单核苷酸多态性突变和拷贝数变异(CNV)数据,并从 MSKCC 数据集中收集了 140 例 PCa 样本。我们提取了434个anoikis相关基因,并利用无监督共识聚类分析确定了分子亚型。对亚型的免疫浸润、分子功能和基因组改变进行了评估。利用 Cox 回归分析建立了风险特征,并通过 MSKCC 数据集进行了验证。我们还确定了针对高危人群的潜在药物。与 C2 相比,C1 表现出更高的 CNV 扩增水平、免疫评分、基质评分、非整倍体评分、同源重组缺陷、瘤内异质性、单核苷酸变异新抗原和肿瘤突变负荷。C2 的生存率更高,γ δ T 细胞和活化 B 细胞浸润水平更高。由四个基因(HELLS、ZWINT、ABCC5 和 TPSB2)组成的风险特征(曲线下面积 = 0.780)被发现是影响 PCa 患者总生存期的独立预后因素。结论本研究中开发的anoikis相关预后模型可作为临床决策的有用工具。这项研究可能会为anoikis相关PCa的治疗提供一个新的视角。
{"title":"Identification and validation of a novel anoikis‐related prognostic model for prostate cancer","authors":"Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Feng","doi":"10.1002/mgg3.2419","DOIUrl":"https://doi.org/10.1002/mgg3.2419","url":null,"abstract":"BackgroundAnoikis resistance is a hallmark characteristic of oncogenic transformation, which is crucial for tumor progression and metastasis. The aim of this study was to identify and validate a novel anoikis‐related prognostic model for prostate cancer (PCa).MethodsWe collected a gene expression profile, single nucleotide polymorphism mutation and copy number variation (CNV) data of 495 PCa patients from the TCGA database and 140 PCa samples from the MSKCC dataset. We extracted 434 anoikis‐related genes and unsupervised consensus cluster analysis was used to identify molecular subtypes. The immune infiltration, molecular function, and genome alteration of subtypes were evaluated. A risk signature was developed using Cox regression analysis and validated with the MSKCC dataset. We also identify potential drugs for high‐risk group patients.ResultsTwo subtypes were identified. C1 exhibited a higher level of CNV amplification, immune score, stromal score, aneuploidy score, homologous recombination deficiency, intratumor heterogeneity, single‐nucleotide variant neoantigens, and tumor mutational burden compared to C2. C2 showed a better survival outcome and had a high level of gamma delta T cell and activated B cell infiltration. The risk signature consisting of four genes (HELLS, ZWINT, ABCC5, and TPSB2) was developed (area under the curve = 0.780) and was found to be an independent prognostic factor for overall survival in PCa patients. Four CTRP‐derived and four PRISM‐derived compounds were identified for high‐risk patients.ConclusionsThe anoikis‐related prognostic model developed in this study could be a useful tool for clinical decision‐making. This study may provide a new perspective for the treatment of anoikis‐related PCa.","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140594505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phosphoserine aminotransferase deficiency diagnosed by whole-exome sequencing and LC-MS/MS reanalysis: A case report and review of literature. 通过全外显子组测序和 LC-MS/MS 重新分析确诊的磷酸丝氨酸氨基转移酶缺乏症:病例报告和文献综述。
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-01 DOI: 10.1002/mgg3.2400
Jiaci Li, Xinping Wei, Yuchen Sun, Xiaofang Chen, Ying Zhang, Xiaoyu Cui, Jianbo Shu, Dong Li, Chunquan Cai

Background: Phosphoserine aminotransferase deficiency (PSATD) is an autosomal recessive disorder associated with hypertonia, psychomotor retardation, and acquired microcephaly. Patients with PSATD have low concentrations of serine in plasma and cerebrospinal fluid.

Methods: We reported a 2-year-old female child with developmental delay, dyskinesia, and microcephaly. LC-MS/MS was used to detect amino acid concentration in the blood and whole-exome sequencing (WES) was used to identify the variants. PolyPhen-2 web server and PyMol were used to predict the pathogenicity and changes in the 3D model molecular structure of protein caused by variants.

Results: WES demonstrated compound heterozygous variants in PSAT1, which is associated with PSATD, with a paternal likely pathogenic variant (c.235G>A, Gly79Arg) and a maternal likely pathogenic variant (c.43G>C, Ala15Pro). Reduced serine concentration in LC-MS/MS further confirmed the diagnosis of PSATD in this patient.

Conclusions: Our findings demonstrate the importance of WES combined with LC-MS/MS reanalysis in the diagnosis of genetic diseases and expand the PSAT1 variant spectrum in PSATD. Moreover, we summarize all the cases caused by PSAT1 variants in the literature. This case provides a vital reference for the diagnosis of future cases.

背景:磷酸丝氨酸氨基转移酶缺乏症(PSATD)是一种常染色体隐性遗传疾病,与肌张力过高、精神运动迟缓和后天性小头畸形有关。PSATD 患者血浆和脑脊液中的丝氨酸浓度较低:我们报告了一名患有发育迟缓、运动障碍和小头畸形的 2 岁女婴。LC-MS/MS 用于检测血液中的氨基酸浓度,全外显子组测序(WES)用于鉴定变异。利用PolyPhen-2网络服务器和PyMol预测变异导致的致病性和蛋白质三维模型分子结构的变化:WES显示了与PSATD相关的PSAT1的复合杂合变异,其中父源变异可能致病(c.235G>A,Gly79Arg),母源变异可能致病(c.43G>C,Ala15Pro)。LC-MS/MS中丝氨酸浓度的降低进一步证实了该患者PSATD的诊断:我们的研究结果证明了 WES 结合 LC-MS/MS 重新分析在遗传病诊断中的重要性,并扩大了 PSATD 中 PSAT1 变异谱。此外,我们还总结了文献中所有由 PSAT1 变体引起的病例。该病例为今后的病例诊断提供了重要参考。
{"title":"Phosphoserine aminotransferase deficiency diagnosed by whole-exome sequencing and LC-MS/MS reanalysis: A case report and review of literature.","authors":"Jiaci Li, Xinping Wei, Yuchen Sun, Xiaofang Chen, Ying Zhang, Xiaoyu Cui, Jianbo Shu, Dong Li, Chunquan Cai","doi":"10.1002/mgg3.2400","DOIUrl":"10.1002/mgg3.2400","url":null,"abstract":"<p><strong>Background: </strong>Phosphoserine aminotransferase deficiency (PSATD) is an autosomal recessive disorder associated with hypertonia, psychomotor retardation, and acquired microcephaly. Patients with PSATD have low concentrations of serine in plasma and cerebrospinal fluid.</p><p><strong>Methods: </strong>We reported a 2-year-old female child with developmental delay, dyskinesia, and microcephaly. LC-MS/MS was used to detect amino acid concentration in the blood and whole-exome sequencing (WES) was used to identify the variants. PolyPhen-2 web server and PyMol were used to predict the pathogenicity and changes in the 3D model molecular structure of protein caused by variants.</p><p><strong>Results: </strong>WES demonstrated compound heterozygous variants in PSAT1, which is associated with PSATD, with a paternal likely pathogenic variant (c.235G>A, Gly79Arg) and a maternal likely pathogenic variant (c.43G>C, Ala15Pro). Reduced serine concentration in LC-MS/MS further confirmed the diagnosis of PSATD in this patient.</p><p><strong>Conclusions: </strong>Our findings demonstrate the importance of WES combined with LC-MS/MS reanalysis in the diagnosis of genetic diseases and expand the PSAT1 variant spectrum in PSATD. Moreover, we summarize all the cases caused by PSAT1 variants in the literature. This case provides a vital reference for the diagnosis of future cases.</p>","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140306264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical mandibulofacial dysostosis with microcephaly diagnosed through the identification of a novel pathogenic mutation in EFTUD2. 通过鉴定 EFTUD2 的新型致病突变,诊断出伴有小头畸形的非典型下颌骨面部发育不良症。
IF 2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-01 DOI: 10.1002/mgg3.2426
Ying Chen, Run Yang, Xin Chen, Naier Lin, Chenlong Li, Yaoyao Fu, Aijuan He, Yimin Wang, Tianyu Zhang, Jing Ma

Background: Mandibulofacial dysostosis with microcephaly (MFDM, OMIM# 610536) is a rare monogenic disease that is caused by a mutation in the elongation factor Tu GTP binding domain containing 2 gene (EFTUD2, OMIM* 603892). It is characterized by mandibulofacial dysplasia, microcephaly, malformed ears, cleft palate, growth and intellectual disability. MFDM can be easily misdiagnosed due to its phenotypic overlap with other craniofacial dysostosis syndromes. The clinical presentation of MFDM is highly variable among patients.

Methods: A patient with craniofacial anomalies was enrolled and evaluated by a multidisciplinary team. To make a definitive diagnosis, whole-exome sequencing was performed, followed by validation by Sanger sequencing.

Results: The patient presented with extensive facial bone dysostosis, upward slanting palpebral fissures, outer and middle ear malformation, a previously unreported orbit anomaly, and spina bifida occulta. A novel, pathogenic insertion mutation (c.215_216insT: p.Tyr73Valfs*4) in EFTUD2 was identified as the likely cause of the disease.

Conclusions: We diagnosed this atypical case of MFDM by the detection of a novel pathogenetic mutation in EFTUD2. We also observed previously unreported features. These findings enrich both the genotypic and phenotypic spectrum of MFDM.

背景:下颌骨面部发育不良伴小头畸形(MFDM,OMIM# 610536)是一种罕见的单基因遗传病,由含有伸长因子 Tu GTP 结合域的 2 基因(EFTUD2,OMIM* 603892)突变引起。该病的特征是下颌骨面部发育不良、小头畸形、畸形耳、腭裂、生长和智力障碍。由于其表型与其他颅面骨骼发育不良综合征重叠,MFDM 很容易被误诊。中颅颌面发育异常综合征的临床表现在不同患者之间存在很大差异:方法:多学科团队对一名颅面畸形患者进行了登记和评估。为了明确诊断,进行了全外显子组测序,然后通过桑格测序进行验证:结果:患者面部骨骼广泛发育不良、睑裂向上倾斜、外耳和中耳畸形、以前未报道过的眼眶异常和闭锁性脊柱裂。EFTUD2 中的一个新型致病性插入突变(c.215_216insT: p.Tyr73Valfs*4)被确定为可能的致病原因:结论:我们通过检测 EFTUD2 中的新型致病基因突变,诊断出了这例非典型 MFDM。我们还观察到了以前未报道过的特征。这些发现丰富了 MFDM 的基因型和表型谱。
{"title":"Atypical mandibulofacial dysostosis with microcephaly diagnosed through the identification of a novel pathogenic mutation in EFTUD2.","authors":"Ying Chen, Run Yang, Xin Chen, Naier Lin, Chenlong Li, Yaoyao Fu, Aijuan He, Yimin Wang, Tianyu Zhang, Jing Ma","doi":"10.1002/mgg3.2426","DOIUrl":"10.1002/mgg3.2426","url":null,"abstract":"<p><strong>Background: </strong>Mandibulofacial dysostosis with microcephaly (MFDM, OMIM# 610536) is a rare monogenic disease that is caused by a mutation in the elongation factor Tu GTP binding domain containing 2 gene (EFTUD2, OMIM* 603892). It is characterized by mandibulofacial dysplasia, microcephaly, malformed ears, cleft palate, growth and intellectual disability. MFDM can be easily misdiagnosed due to its phenotypic overlap with other craniofacial dysostosis syndromes. The clinical presentation of MFDM is highly variable among patients.</p><p><strong>Methods: </strong>A patient with craniofacial anomalies was enrolled and evaluated by a multidisciplinary team. To make a definitive diagnosis, whole-exome sequencing was performed, followed by validation by Sanger sequencing.</p><p><strong>Results: </strong>The patient presented with extensive facial bone dysostosis, upward slanting palpebral fissures, outer and middle ear malformation, a previously unreported orbit anomaly, and spina bifida occulta. A novel, pathogenic insertion mutation (c.215_216insT: p.Tyr73Valfs*4) in EFTUD2 was identified as the likely cause of the disease.</p><p><strong>Conclusions: </strong>We diagnosed this atypical case of MFDM by the detection of a novel pathogenetic mutation in EFTUD2. We also observed previously unreported features. These findings enrich both the genotypic and phenotypic spectrum of MFDM.</p>","PeriodicalId":18852,"journal":{"name":"Molecular Genetics & Genomic Medicine","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140336205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Genetics & Genomic Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1